EUVIMEDEUVIMED entdecken
Crossref

Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate

Keita Ito, Hiroto Furukawa, Hiroshi Inaba iD, Shino Ohshima, Yoshie Kametani, Masatoshi Maeki iD, Manabu Tokeshi iD, Xuhao Huang, Kazuya Kabayama iD, Yoshiyuki Manabe iD, Koichi Fukase iD, Kazunori Matsuura iD

Journal of the American Chemical Society · 2023

DOI: 10.1021/jacs.3c02679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2023. Verfasst von Keita Ito und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Sekisui Chemical, Core Research for Evolutional Science and Technology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesNeoplasmsLipid BilayersAntigensAdjuvants, ImmunologicPeptidesGalactosylceramides

Substanzen

Cancer VaccinesLipid BilayersAntigensAdjuvants, ImmunologicPeptidesalpha-galactosylceramideGalactosylceramides

Autor:innen und Institutionen

  • Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan.
  • Department of Chemistry and Biotechnology, Graduate School of Engineering, Tottori University, 4-101 Koyama-Minami, Tottori 680-8552, Japan.
  • Center for Research on Green Sustainable Chemistry, Tottori University, 4-101 Koyama-Minami, Tottori 680-8552, Japan.
  • School of Medicine, Tokai University, Isehara 259-1193, Kanagawa, Japan.
  • Division of Applied Chemistry, Faculty of Engineering, Hokkaido University, Sapporo 060-8628, Hokkaido, Japan.
  • Forefront Research Center, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, Japan.

ORCID-Profile: Hiroshi Inaba, Masatoshi Maeki, Manabu Tokeshi, Kazuya Kabayama, Yoshiyuki Manabe, Koichi Fukase, Kazunori Matsuura

Förderung

  • Sekisui Chemical
  • Core Research for Evolutional Science and Technology
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Japan Initiative for World-leading Vaccine Research and Development Centers

Zitieren

APA

Ito, K., Furukawa, H., Inaba, H., Ohshima, S., Kametani, Y., Maeki, M., Tokeshi, M., Huang, X., Kabayama, K., Manabe, Y., Fukase, K., & Matsuura, K. (2023). Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.3c02679

Vancouver

Ito K, Furukawa H, Inaba H, Ohshima S, Kametani Y, Maeki M, et al. Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate. Journal of the American Chemical Society. 2023. doi:10.1021/jacs.3c02679

BibTeX
@article{Ito2023,
  author = {Ito, Keita and Furukawa, Hiroto and Inaba, Hiroshi and Ohshima, Shino and Kametani, Yoshie and Maeki, Masatoshi and Tokeshi, Manabu and Huang, Xuhao and Kabayama, Kazuya and Manabe, Yoshiyuki and Fukase, Koichi and Matsuura, Kazunori},
  title = {Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate},
  journal = {Journal of the American Chemical Society},
  year = {2023},
  doi = {10.1021/jacs.3c02679}
}
Kostenlos starten →